Bolder Surgical, formerly known as JustRight Surgical, said today that it raised $27 million in a new round of financing to support its laparoscopic surgical devices.

The round was led by River City Capital Funds and joined by Westwood Management, Providence Ventures and previous investors, the Louisville, Colo.-based company said. Funds raised in the round will support the company’s product innovation pipeline, increases in workforce and scaling commercialization.

In connection with the round, Westwood Management managing partner Lair Kennedy and River Cities Capital managing partner Carter McNabb will join the company’s board of directors.

The company announced its rebranding to Bolder Surgical along with the financing, saying that it hopes the move to the new moniker will “better align the company with its long-term vision of a robust product portfolio that expands beyond pediatric care.”

“I am extremely pleased with the investment led by River Cities Capital Funds, which will enable the company to continue to innovate and create safer procedural approaches that improve physician control and patient outcomes. Support from our highly respected investors further validates the company’s innovative technology and the positive impact our instruments have on patients, surgeons and the healthcare system. Bolder Surgical revolutionized minimally invasive surgery in children by providing right-sized instruments that improve access and visibility in the tiniest patients. While our name has changed from JustRight, we remain committed to leveraging our technical expertise in micro-device technology and energy delivery to elevate expectations for all surgical procedures. Bolder Surgical defines our evolved vision and increases the opportunity to impact the lives of more patients,” CEO Robert Kline said in a press release.

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW